Agea Medical is $2 million shy of its $8 million funding round goal
Officials at Agea Medical said it is closing in on an $8 million funding round.
The Redwood City, Calif.-based medical device company has raised $6 million for its coffers and is close to its goal.
Agea markets a system that uses vapor to ablate uterine cavity tissues. The company develops medical technology to treat excessive menstrual bleeding, a condition the company says impacts 1 in 4 women in the U.S.
In 2011, the company landed a $13.3 million private equity funding round led by medical device giant Covidien.
Company SEC filings did not disclose the investors involved in the current offering.
Intersect ENT enrolls the 1st patient in its PROGRESS study, aiming to expand the patient population...
Innovative needle design to enhance patient safety.
Medtronic taps Dr. Elizabeth Nabel, president of Brigham & Women's Faulkner Hospital in Boston,...
NxStage Medical wins FDA clearance to market its OneSite single needle dialysis technology for use...